Biology subjects

Dura, K.

Publications and source records attributed to Dura, K..

4 recordsLinked to original sources

bioRxiv2026

Modeling gene regulatory perturbations via deep learning from high-throughput reporter assays

Assessing likely variant effects on phenotypes is of critical importance in diagnostic settings, and while much progress has been made in interpreting genic mutations based on our understanding of coding sequence, noncoding variants can be much more challenging to reliably interpret based on DNA sequence alone. High-throughput reporter assays such as STARR-seq and MPRA have shown utility in experimentally measuring regulatory effects of noncoding variants present in samples but provide no readout for variants not present in the assay inputs. However, whole-genome reporter assays provide copious data that can be used to train predictive models for prioritizing variants not directly observed in the experiment. We describe a retrainable predictive modeling framework, BlueSTARR, for this task, and present results of training several models with this framework on whole-genome STARR-seq data from two cell lines and one drug treatment. Using these models, we uncover a global signature across the human genome consistent with purifying selection against both loss-of-function and gain-of-function regulatory variants, with the latter showing a significant bias consistent with selection against gains of cis regulatory function in closed chromatin proximal to genes. By testing the model on synthetic enhancers with binding motifs for transcription factors GR and AP-1, we find that when trained on drug perturbation data, the model is able to learn distance-dependent and treatment-dependent binding patterns and their resulting reporter gene activation. These results demonstrate that lightweight, easily retrainable models such as ours have utility in probing latent signals present in novel experimental data. Finally, we find only modest differences in performance between different deep-learning architectures when trained on this single data modality, and while somewhat greater predictive accuracy can be achieved with much larger models trained at great expense on many terabytes of data, there is still copious room for improvement even for industrial strength, state-of-the-art models.

bioinformatics↗

bioRxiv2026

Structured Pooling Improves Detection of Rare Regulatory Mutations in Population-Scale Reporter Assays

Identifying genetic variants in noncoding DNA that impact gene expression and thereby contribute to disease risk remains a difficult but important challenge in genomic medicine. Modern reporter assays such as STARR-seq and MPRA provide an efficient and effective means of testing, in very high throughput, millions of variants captured directly from patient genomes. While these assays have previously been scaled to whole genomes and, separately, to populations, we report findings from the first whole-genome population-scale STARR-seq experiment performed on 100 individuals. In order to achieve that scale we devised a novel experimental design that partitions samples into pools so as to increase allele frequencies within pools and thereby reduce expected dropout and increase signal-to-noise ratio in experimental readouts. We show that this design produces more accurate estimates of variant effect sizes, and we provide a Bayesian model for robust estimation of those effect sizes that also reports full posterior distributions for assessment of confidence in estimates. Together, these methodological innovations facilitate the detection of functional regulatory variants, particularly rare variants, with much higher accuracy and at greater scale than previously possible. We demonstrate the utility of this approach on the task of functional annotation of quantitative trait loci such as eQTLs and caQTLs, and show concordance with patterns of constraint in transcription factor binding profiles.

bioinformatics↗

bioRxiv2025

The architecture of allele-specific regulatory variant effects across five human genomes

The overwhelming majority of genetic associations with complex traits and disease involve non-coding genetic variants. Those variants are substantially enriched in gene regulatory elements, indicating that allelic impacts on gene regulatory element activity is a major contributor to those associations. As a step towards fine mapping the mechanisms within those associations, several studies have identified variants associated with gene expression and chromatin accessibility within those phenotypic associations. However, connecting those associations with functional impacts on gene regulatory element activity remains a major challenge. Here, we functionally measured allele-specific regulatory element activity across five human genomes using the genome-wide reporter assay STARR-seq. We identified tens of thousands of gene regulatory elements and estimated allele effects at [~]200,000 genetic variants therein, including [~]10,000 indels in our study population. Allelic effects on regulatory element activity correspond closely with predicted impacts on transcription factor binding motifs. The measured variant effects also allow us to fine map potential causal variants within eQTLs and chromatin QTLs from the same population. Together, these results provide an initial atlas of genome-wide variant effects across the human genome and demonstrate the potential for such approaches to prioritize causal variants for future mechanistic investigation.

genomics↗

bioRxiv2024

A consensus variant-to-function score to functionally prioritize variants for disease

Identifying and functionally characterizing causal disease variants in genome-wide association studies remains a pressing challenge. Here, we construct a consensus variant-to-function (cV2F) score that assigns a single value to each common single-nucleotide variant in the genome, and helps to predict and characterize causal disease variants. The cV2F score leverages features reflecting variant-level experimentally and computationally predicted function (e.g. allelic imbalance and sequence-based deep learning models) and element-level function (e.g. predicted enhancers), and learns optimal combinations of features by training a gradient boosting model on GWAS fine-mapping results. The cV2F-annotated variants attained an AUPRC of 0.822 at identifying held-out fine-mapped variants. Variants with high cV2F scores are highly enriched for heritability (14.2x, s.e. 0.5) across 66 diseases/traits, are uniquely informative for disease heritability, and are highly predictive of variants implicated by reporter assays; cV2F substantially outperforms previous variant-to-function scores using all of these metrics. GWAS fine-mapping of 110 diseases/traits informed by cV2F identified 14.3% more confidently fine-mapped (PIP > 0.95) variants than non-functionally informed fine-mapping. We further constructed tissue/cell line-specific cV2F scores that prioritize variants based on regulatory potential in specific tissues/cell lines, attaining high heritability enrichment for tissue-related diseases/traits (15.6x, s.e. 2.3) while providing independent information (average correlation of 0.27 with the primary cV2F score). We highlight examples of GWAS loci for which cV2F pinpoints causal variants with high confidence and elucidates their functional role.

genetics↗